SpeeDx Pty, Ltd., a developer of innovative molecular diagnostic solutions, today announced an agreement with Cepheid for distribution of its PlexPCR™ and ResistancePlus™ molecular diagnostic products in key markets throughout Europe. The agreement, covering Germany, France, Italy, and the UK,...
but resistance to these antibiotics has increased up to 50% in several countries.4-6Due to this growing antibiotic resistance problem, several global STI Management Guidelines on Mgen Infections recommend complementing the use of molecular testing to detectM...
4 Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea * Authors to whom correspondence should be addressed. † These authors contributed equally to this work. (This article belongs to the Special IssueMolecular Genetics & Diagnosis of Infectious ...